DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment
In this study, we investigated the feasibility of dipalmitoylphosphatidylcholine-coated lipid nanoparticles (DPPC-LNs) as a carrier for preferential accumulation into lungs of Resveratrol (Res), a potentially promising drug for the treatment of pulmonary arterial hypertension (PAH). Res-loaded DPPC-...
Saved in:
Main Authors: | Zerong Li (Author), Wenmei Qiao (Author), Chenghao Wang (Author), Heqiao Wang (Author), Mengchao Ma (Author), Xinyu Han (Author), Jingling Tang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Fetus Can Teach Us: Oxygen and the Pulmonary Vasculature
by: Payam Vali, et al.
Published: (2017) -
Aberrant Expression of ACO1 in Vasculatures Parallels Progression of Idiopathic Pulmonary Fibrosis
by: Jutaro Fukumoto, et al.
Published: (2022) -
Interaction Between Blood Vasculatures and Lymphatic Vasculatures During Inflammation
by: Wang SS, et al.
Published: (2023) -
Phenylalanine and Tryptophan-Based Surfactants as New Antibacterial Agents: Characterization, Self-Aggregation Properties, and DPPC/Surfactants Vesicles Formulation
by: Zakaria Hafidi, et al.
Published: (2023) -
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
by: S. Chennakesavulu, et al.
Published: (2018)